{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:14:01Z","timestamp":1774296841566,"version":"3.50.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T00:00:00Z","timestamp":1339113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0038859","type":"journal-article","created":{"date-parts":[[2012,6,9]],"date-time":"2012-06-09T02:51:31Z","timestamp":1339210291000},"page":"e38859","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["High Quality Long-Term CD4+ and CD8+ Effector Memory Populations Stimulated by DNA-LACK\/MVA-LACK Regimen in Leishmania major BALB\/c Model of Infection"],"prefix":"10.1371","volume":"7","author":[{"given":"Lucas","family":"S\u00e1nchez-Sampedro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Elena","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Mej\u00edas-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Oscar","family":"S. Sorzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,6,8]]},"reference":[{"key":"ref1","article-title":"Scientific Working Group Report on Leishmaniasis.","year":"2004"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2013challenges and opportunities.","volume":"17","author":"SL Croft","year":"2011","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"key":"ref3","first-page":"134","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines.","volume":"30(2)","author":"MS Duthie","year":"2011","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.vaccine.2003.10.046","article-title":"A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major.","volume":"22","author":"SBH Ahmed","year":"2004","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen.","volume":"268","author":"E Mougneau","year":"1995","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.","volume":"69","author":"PC Melby","year":"2001","journal-title":"Infect Immun"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1074-7613(00)80342-8","article-title":"IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB\/c mice.","volume":"6","author":"P Launois","year":"1997","journal-title":"Immunity"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.274.5286.421","article-title":"Resistance to Leishmania major induced by tolerance to a single antigen.","volume":"274","author":"V Julia","year":"1996","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design.","volume":"8","author":"Ra Seder","year":"2008","journal-title":"Nature reviews Immunology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-3024.2009.01125.x","article-title":"Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis.","volume":"31","author":"DR Faria","year":"2009","journal-title":"Parasite Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.1371\/journal.pntd.0000845","article-title":"CD8+ T cells as a source of IFN-gamma production in human cutaneous leishmaniasis.","volume":"4","author":"M Nateghi Rostami","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-3024.2010.01268.x","article-title":"The magnitude of CD4(+) T-cell activation rather than TCR diversity determines the outcome of Leishmania infection in mice.","volume":"33","author":"L Xin","year":"2011","journal-title":"Parasite Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2011.04430.x","article-title":"CD4(+) T cells defined by their Vbeta T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.","volume":"165","author":"TS Keesen","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2012.02.006","article-title":"Phenotyping of circulating CD8(+) T cell subsets in human cutaneous leishmaniasis.","author":"A Khamesipour","year":"2012"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.","volume":"13","author":"Pa Darrah","year":"2007","journal-title":"Nature medicine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.20092532","article-title":"IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform.","volume":"207","author":"PA Darrah","year":"2010","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1016\/j.vaccine.2009.08.091","article-title":"Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection.","volume":"27","author":"I Ramos","year":"2009","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tvjl.2009.08.001","article-title":"Determination of CD4+ and CD8+ T cells in the peripheral blood of dogs with leishmaniosis before and after prolonged allopurinol monotherapy.","volume":"186","author":"E Papadogiannakis","year":"2010","journal-title":"Vet J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.micinf.2005.10.004","article-title":"MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis.","volume":"8","author":"E P\u00e9rez-Jim\u00e9nez","year":"2006","journal-title":"Microbes and infection"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","article-title":"Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.","volume":"26","author":"I Ramos","year":"2008","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nri1416","article-title":"Seventeen-colour flow cytometry: unravelling the immune system.","volume":"4","author":"SP Perfetto","year":"2004","journal-title":"Nature reviews Immunology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.micinf.2007.05.017","article-title":"Different epitopes of the LACK protein are recognized by V beta 4 V alpha 8 CD4+ T cells in H-2b and H-2d mice susceptible to Leishmania major.","volume":"9","author":"P Launois","year":"2007","journal-title":"Microbes and infection"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2011.04.011","article-title":"Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection.","volume":"153","author":"D Doroud","year":"2011","journal-title":"J Control Release"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines.","volume":"201","author":"DC Tscharke","year":"2005","journal-title":"J Exp Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/IAI.73.8.5286-5289.2005","article-title":"Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis.","volume":"73","author":"B Dondji","year":"2005","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1286-4579(02)00077-1","article-title":"The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36\/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36\/LACK.","volume":"5","author":"E Tapia","year":"2003","journal-title":"Microbes and infection"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1016\/j.vaccine.2009.08.091","article-title":"Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection.","volume":"27","author":"I Ramos","year":"2009","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1074-7613(00)80342-8","article-title":"IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB\/c mice.","volume":"6","author":"P Launois","year":"1997","journal-title":"Immunity"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.4049\/jimmunol.160.2.884","article-title":"Control of Leishmania major by a monoclonal alpha beta T cell repertoire.","volume":"160","author":"SL Reiner","year":"1998","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.189.7.1111","article-title":"Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope.","volume":"189","author":"S Pingel","year":"1999","journal-title":"J Exp Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.","volume":"145","author":"FY Liew","year":"1990","journal-title":"Journal of immunology"},{"key":"ref32","first-page":"1131","article-title":"Tumor necrosis factor-a in combination with intederon, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes.","author":"C Bogdan","year":"1990"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.4049\/jimmunol.145.12.4290","article-title":"Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.","volume":"145","author":"SJ Green","year":"1990","journal-title":"J Immunol"},{"key":"ref34","first-page":"304","article-title":"TNF-a reverses the disease-exacerbating effect of subcutaneous immunization against murine cutaneous leishmaniasis.","volume":"39","author":"FY Liew","year":"1991","journal-title":"Immunology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/IAI.70.1.240-248.2002","article-title":"Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.","volume":"70","author":"J Cote-Sierra","year":"2002","journal-title":"Infect Immun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.4049\/jimmunol.0903080","article-title":"Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.","volume":"184","author":"A Haque","year":"2010","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.166.6.4012","article-title":"Rapidly fatal leishmaniasis in resistant C57BL\/6 mice lacking TNF.","volume":"166","author":"P Wilhelm","year":"2001","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1128\/IAI.68.11.6289-6293.2000","article-title":"Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment.","volume":"68","author":"HW Murray","year":"2000","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.4049\/jimmunol.1100302","article-title":"CD8+ T effector memory cells protect against liver-stage malaria.","volume":"187","author":"A Reyes-Sandoval","year":"2011","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/IAI.01190-10","article-title":"Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.","volume":"79","author":"PO Rigato","year":"2011","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2249.2011.04536.x","article-title":"Multifunctional CD4 T cells in patients with American cutaneous leishmaniasis.","volume":"167","author":"AB Macedo","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<525::AID-IMMU525>3.0.CO;2-M","article-title":"The induction of a protective response in Leishmania major-infected BALB\/c mice with anti-CD40 mAb.","volume":"28","author":"WG Ferlin","year":"1998","journal-title":"Eur J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.4049\/jimmunol.172.10.6209","article-title":"Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.","volume":"172","author":"MM Gherardi","year":"2004","journal-title":"Journal of immunology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/icb.1997.60","article-title":"DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors.","volume":"75","author":"aJ Ramsay","year":"1997","journal-title":"Immunology and cell biology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1432-1327.1999.00122.x","article-title":"Molecular cloning, cell localization and binding affinity to DNA replication proteins of the p36\/LACK protective antigen from Leishmania infantum.","volume":"259","author":"G Gonzalez-Aseguinolaza","year":"1999","journal-title":"European journal of biochemistry\/FEBS"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/JVI.02216-07","article-title":"Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates.","volume":"82","author":"P Mooij","year":"2008","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e12395","DOI":"10.1371\/journal.pone.0012395","article-title":"Immunogenic profiling in mice of a HIV\/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions.","volume":"5","author":"J Garcia-Arriaza","year":"2010","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e11406","DOI":"10.1371\/journal.pone.0011406","article-title":"Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens.","volume":"5","author":"JL Najera","year":"2010","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0038859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T07:14:28Z","timestamp":1687504468000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0038859"}},"subtitle":[],"editor":[{"given":"Mauricio Martins","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,6,8]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0038859","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,8]]}}}